Skip to content
Wall Street PR

Wall Street PR

  • Home
  • Recent Stories
  • Market News
  • Crypto
  • FB
  • TW
  • YT
  • TIKTOK

Ad code paste Below

Cesca Therapeutics Inc.

Cesca Therapeutics Inc. (NASDAQ:KOOL) Issues Favorable 40-Month Follow-Up Results Of SurgWerks Feasibility Study

Cesca Therapeutics Inc. (NASDAQ:KOOL) has disclosed on Wednesday 40-month follow-up results of its feasibility study evaluating SurgWerks for the treatment of late-stage, no-option critical limb […]

Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV)

Boston, MA 10/14/2014 (wallstreetpr) – Dynavax Technologies Corporation (NASDAQ:DVAX) announced on 13th October that it had initiated phase 1/2 clinical trials of its drug candidate […]

About WallStreetPR

WallStreetPR.com is a comprehensive publisher reporting on the pulse of the North American stock markets. The site is an innovator in business news, videos and insightful market content that generates hundreds of articles weekly. From Wall Street to Bay Street, WallStreetPR.com covers news from companies big and small with our journalists

Social Menu WallStreetPR

  • FB
  • TW
  • YT
  • TIKTOK

Stocks

  • Featured
  • Latest
  • OTC
  • Nasdaq
  • NYSE
  • Blockchain News
  • Digital News
  • Stock Reports
  • Cryptocurrency
  • Cannabis
  • Advancers
  • Automobile
  • Banking
  • Business
  • Decliners
  • Energy
  • Health
  • Hot News
  • Industrials
  • International
  • Media
  • Metals
  • Mining
  • NASDAQ high profiles
  • Retail
  • Rumors
  • Small Cap Stock News
  • Technology
  • Pot Stocks

Quick Links

  • About Us
  • Contact
  • Privacy Policy
  • Disclaimer
  • Advertise
Copyright © 2019 - 2023 Wall Street PR . All rights reserved.
Wall Street PR
  • FB
  • TW
  • YT
  • TIKTOK
  • Home
  • Recent Stories
  • Market News
  • Crypto